Literature DB >> 10647598

Clinical application of 201Tl SPECT imaging of brain tumors.

D Sun1, Q Liu, W Liu, W Hu.   

Abstract

UNLABELLED: This study investigated the clinical usefulness of evaluating the histologic grade of brain tumors by 201Tl SPECT brain imaging.
METHODS: Early and delayed SPECT brain images were obtained about 10 min and 3 h, respectively, after intravenous injection of 111MBq (3 mCi) 201Tl in 9 healthy subjects (control subjects), 3 patients with brain hematomas, and 41 patients with brain tumors. Semiquantitative data were obtained for early and delayed 201Tl uptake indices and 201Tl retained index in all patients and healthy subjects.
RESULTS: In 9 healthy subjects, there was little radioactivity in brain substance. In all patients with brain hematomas or tumors, a high tracer uptake was visible in lesions on early images, but the radioactivity in lesions varied with the histologic nature of the lesion on delayed images. The radioactivity decreased remarkably in brain hematomas (average retained index, 0.61 +/- 0.04). The radioactivity was stable or decreased slightly in benign or low-grade tumors (average retained index, 0.96 +/- 0.24). The radioactivity was increased in high-grade or metastatic tumors (average retained index, 1.26 +/- 0.28).
CONCLUSION: This study indicates that 201Tl brain SPECT early and delayed imaging is very useful in brain tumor localization, in distinguishing low-grade from high-grade brain tumors, in predicting histologic grades of brain tumors, and in detecting residual or recurrence of brain tumors postoperatively. 201Tl brain SPECT may also offer the most accurate assessment of response to therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647598

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Clinical significance of thallium-201 SPECT after postoperative radiotherapy in patients with glioblastoma multiforme.

Authors:  Gyo Iida; Kazuhiko Ogawa; Shogo Ishiuchi; Itaru Chiba; Takashi Watanabe; Naofumi Katsuyama; Yoshihiko Yoshii; Sadayuki Murayama
Journal:  J Neurooncol       Date:  2010-09-02       Impact factor: 4.130

2.  Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma.

Authors:  Sho Osawa; Masahiko Tosaka; Keishi Horiguchi; Azusa Tokue; Tetsuya Higuchi; Yoshito Tsushima; Yuhei Yoshimoto
Journal:  Int J Clin Oncol       Date:  2022-05-13       Impact factor: 3.850

3.  Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.

Authors:  Ana Paula Caresia; Joan Castell-Conesa; Montserra Negre; Antoni Mestre; Gemma Cuberas; Anabel Mañes; Xavier Maldonado
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

4.  CT-based quantitative SPECT for the radionuclide ²⁰¹Tl: experimental validation and a standardized uptake value for brain tumour patients.

Authors:  Kathy Willowson; Dale Bailey; Geoff Schembri; Clive Baldock
Journal:  Cancer Imaging       Date:  2012       Impact factor: 3.909

5.  Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.

Authors:  Moritaka Yamauchi; Tomohisa Okada; Tsutomu Okada; Akira Yamamoto; Yasutaka Fushimi; Yoshiki Arakawa; Susumu Miyamoto; Kaori Togashi
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

6.  Voxel-based analysis of (201)Tl SPECT for grading and diagnostic accuracy of gliomas: comparison with ROI analysis.

Authors:  Tomoyuki Kuwako; Sunao Mizumura; Ryusuke Murakami; Tamiko Yoshida; Masato Shiiba; Hidetaka Sato; Yoshimitsu Fukushima; Akira Teramoto; Shin-Ichiro Kumita
Journal:  Ann Nucl Med       Date:  2013-04-17       Impact factor: 2.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.